Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach
-
Emerald Expositions Events (EEX) PT Lowered to $8 at Maxim Group
-
ALT5 Sigma Corporation Announces Participation at the Spartan Capital Investor Conference
-
SRIVARU Holding (SVMH) Prices 106.25M Unit Offering at $0.064/unit
-
SRIVARU (SVMH) Announces Pricing of Upsized $6.8 Million Underwritten Public Offering
-
Brainstorm Cell Therapeutics (BCLI) PT Lowered to $10 at Maxim Group
-
Lending Club (LC) PT Raised to $19 at Maxim Group
-
TuanChe (TC) Prices 761.72K Share Offering at $1.45/sh
-
TuanChe Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement
-
Maxim Group Downgrades PainReform Ltd. (PRFX) to Hold
-
WISeKey (WKEY) Enters Into $30 Million Convertible Notes Subscription Agreements
-
WISeKey Enters Into $30 Million Convertible Notes Subscription Agreements
-
WISeKey Enters Into $30 Million Convertible Notes Subscription Agreements
-
TuHURA Biosciences (Nasdaq: HURA) Announces Webcast Replay of Panel Presentation at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
-
Jet.AI (JTAI) Prices 15.6M Share Offering at $0.096/sh
-
Jet.AI Announces Pricing of $1.5 Million Registered Direct Offering
-
Nicolet Bankshares (NIC) PT Raised to $124 at Maxim Group
-
Maxim Group Downgrades Helius Medical Tech (HSDT) to Hold
-
Maxim Group Starts GameSquare Holdings Inc (GAME) at Buy
-
PetVivo Holdings, Inc. Announces Participation at The Spartan Capital Investor Conference Premier Event to Showcase Growth Companies and Foster High-Level Investor Engagement
-
The Nuvo Group is Recognized as a B2i Digital Featured Expert
-
Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16
-
Rani Therapeutics (RANI) Prices $10M Share and Warrant Offering at $3/sh, Cancels Certain Existing Warrants
-
Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants
-
Maxim Group Starts Ocugen, Inc. (OCGN) at Buy
-
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit
-
Focus Universal Inc. Announces Participation at The Spartan Capital Investor Conference
-
Super League Gaming (SLE) PT Lowered to $3 at Maxim Group
-
Bionomics to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
-
Lineage Cell Therapeutics to Present at the Maxim Group 2024 Virtual Healthcare Summit
-
B2i Digital Named Marketing Partner for Maxim Group's 2024 Healthcare Virtual Summit
-
Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit
-
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024
-
Jet.AI (JTAI) Prices 26.6M Share Offering at $0.09/sh
-
Jet.AI Announces Pricing of $2.4 Million Registered Direct Offering
-
Alzamend Neuro CEO Stephan Jackman to Participate in the Maxim Group’s Virtual Healthcare Conference
-
Zevra Therapeutics to Participate in Rare Disease Panel at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
-
Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
-
Ocugen to Participate in 2024 Maxim Healthcare Virtual Summit
-
BioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor Events
-
Iterum Therapeutics to Participate at the 2024 Maxim Healthcare Virtual Summit
-
Kairos Pharma to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
-
Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit
-
Inhibikase Therapeutics (IKT) Prices $110M Private Placement to Advance IkT-001Pro
-
Inhibikase Therapeutics Announces Pricing of $110 Million Private Placement to Advance IkT-001Pro, an Optimized Prodrug of Imatinib, into a Late-Stage Trial in Pulmonary Arterial Hypertension
-
AIM ImmunoTech to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC
-
Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16th
-
Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit
-
SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit
-
Dermata Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit on Tuesday, October 15, 2024

